UTv Videos

In terms of physician burnout, “The pandemic has only made a bad situation worse,” says Raj S. Pruthi, MD, MHA, FACS.

Loeb and Stork offer pointers for beginners and current users alike.

“I think one of the issues that we face as physicians…is during training, long hours and a lack of control over our schedule indoctrinates surgeons with habits that may be counterproductive to achieving life balance after entering practice,” says Raj S. Pruthi, MD, MHA FACS.

“This paper shows that our efforts to reduce… opioid exposure in the postoperative setting is reducing new persistent opioid use,” says Matthew S. Lee, MD.

“This test requires just one millimeter of cancer on a biopsy on five consecutive slides,” says Eric A. Klein, MD.

“We found that a remarkable percentage of patients were getting narcotics refills from non urologists,” said Jay Simhan, MD, FACS.

“As we suspected, the more work interfered with their freedom to use the restroom, the fewer times they urinated during the work day,” says W. Stuart Reynolds, MD, MPH, FACS.

“For now, the UMPIRE [study] protocol will continue to withhold prophylaxis in the newborn population,” says investigator M. Chad Wallis, MD, FACS.

“The way I think about this test now is… more as a dichotomous score,” says Eric A. Klein, MD.

“The take-home message is that for the appropriate patient, each of [these] technologies works well,” says Richard K. Lee, MD, MBA.

“It’s an extremely useful tool,” says Jonathan D. Tward, MD, PhD, of the Prolaris test.

Investigators observed a decline in the number of men obtaining repeat postvasectomy semen analyses.

“Very, very few patients actually had any counseling documented or any medications ordered that would help with smoking cessation,” says Richard S. Matulewicz, MD.

“I find [the Prolaris test] to be a very helpful clinical tool,” says Jonathan D. Tward, MD, PhD.

“We continue to see a building story of benefit of statin medications in men who have prostate cancer,” says Robert J. Hamilton, MD, MPH.

Chris Du, MD, discusses findings from a study published in Neurourology and Urodynamics.

Investigators evaluated uropathogen prevalence and antibiotic resistance in a urogynecologic patient population.

Attorney Kenton H. Steele, Esq, discusses his recent Urology Times® column.

Rena Malik, MD, discusses findings from a recent Urology Practice study.

Researchers evaluated the use of interprofessional consultations within the specialty of urology.

Only 5% of websites studied discuss risks of treatments, investigators found.

Reza Z. Goharderakhshan, MD, discusses how patient compliance for recommended studies increased from less than 10% to 82% following implementation of the program.

“Listen. Be emphatic. Be transparent,” Pansy Uberoi, MD, MPH, advises in this interview.

Victoria S. Edmonds and Tobias Köhler, MD, MPH, discuss trends in reimbursement for men's health procedures from 2002 to 2020.

Murphy shares the backstory of how PSMA PET/CT imaging has emerged as a major advancement in the prostate cancer armamentarium.

Gomella looks back on the year's top headlines in bladder cancer, from FDA approvals to notable clinical trial results.

“Some women described not being told any risks of the surgery… while other women did recall having risks described,” says investigator Pansy Uberoi, MD, MPH.

Urology residency program applicants continue to face interview questions on restricted topics such as plans for having children.